Find your next paid study

Actual pay is set by the research site.

Mayo ClinicNCT06192875

Advanced Soft Tissue Sarcoma

A Seamless Phase 1/2 Open-label Study to Evaluate the Safety, Determine the Maximum Tolerated Dose of Administered Activity, and Evaluate the Efficacy of the Therapeutic Radiopharmaceutical [Ac 225]-RTX-2358 in the Treatment of Relapsed or Refractory Sarcoma

The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio …

Ratio Therapeutics, Inc.NCT07156565

~$150 – $4,200

Actual pay is set by the research site.

Observational

MEDBRIDGE: AI-Driven Risk Stratification and Care Transition Intervention to Improve Diabetes Medication Management

This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medicati…

Type 2 DiabetesMedication AdherenceCare Transition+1 more

University of Alabama at BirminghamNCT07599852

Actual pay is set by the research site.

Observational

Enhancing Alcohol Treatment Engagement in ALD Patients

The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engageme…

Henry Ford Health SystemNCT06269510

Actual pay is set by the research site.

Observational

RIsEStroke (Recovery Insights Into Early Mobility Post Stroke)

This study is designed to better understand how patients with severe stroke move during their hospital stay. It will track their activity using a small wearabl…

Acute Ischemic Stroke

Wake Forest University Health SciencesNCT07638462

Actual pay is set by the research site.

Pancreatic Adenocarcinoma Metastatic

Phase 1b Dose Escalation Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine…

Oncomatryx Biopharma S.L.NCT07377045

~$150 – $4,200

Actual pay is set by the research site.

Chronic Lymphocytic Leukemia (CLL)Refractory Chronic Lymphocytic Leukemia

A Phase 1b and 2 Study of Roginolisib (IOA-244) Combined With Obinutuzumab Followed by Venetoclax in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) After Progression on Prior Bruton Tyrosine Kinase (BTK) Inhibitors

This is a Phase 1b and 2, open-label, single-arm study evaluating the safety, tolerability, and efficacy of roginolisib (IOA-244) in combination with obinutuzu…

Dana-Farber Cancer InstituteNCT07847957

~$150 – $4,500

Actual pay is set by the research site.

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more

A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation

This phase II trial compares the effectiveness of adding BMX-001 to usual symptom management versus usual symptom management alone for reducing oral mucositis …

Chronic Graft Versus Host Disease

Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

This is an open-label phase I study of fostamatinib in combination with ruxolitinib for the treatment of chronic GvHD with a suboptimal response to corticoster…

Stefanie Sarantopoulos, MD, PhD.NCT06233110

~$150 – $4,500

Actual pay is set by the research site.

Obesity in ChildrenBone StrengthGLP - 1+3 more

Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy

The goal of this clinical trial is to compare bone health markers over 24 months in participants 12 - 21 years of age with obesity who are starting the glucago…

University of VirginiaNCT06903923

~$75 – $2,000

Actual pay is set by the research site.

Allogeneic Stem Cell Transplant

Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation

The study will evaluate the safety and early efficacy of administering the combination of a commercially available potato-based resistant starch along with iro…

University of Michigan Rogel Cancer CenterNCT06784336

~$75 – $2,000

Actual pay is set by the research site.

A Phase 2 Trial to Evaluate the Safety and Tolerability of Clazakizumab® [Anti-Interleukin (IL)-6 Monoclonal] Compared to Placebo for the Treatment of COVID-19 Infection

The purpose of this study is to investigate the effectiveness and safety of treatment with clazakizumab compared to a placebo (inactive substance). We are prop…

COVID-19 Infection